BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer

  Mr. Shah has been serving as the Interim President and Chief Executive Officer since March 2017.

  October 31, 2017

   · 

  4 min read
• Business

  Selecta Biosciences to Report Third Quarter 2017 Financial Results and Updated Phase 2 Data for SEL-212 on Tuesday, November 7, 2017

  t 8:30 a.m. ET that day, Selecta will host a conference call to discuss these results and provide a corporate update.

  October 31, 2017

   · 

  3 min read
• GN Store Nord: Transactions in Relation to Share Buyback Program - Oct. 31, 2017

  The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

  October 31, 2017

   · 

  2 min read
• Policy

  Sonoma Pharmaceuticals Receives Brazilian Approvals to Market Multiple Hypochlorous Acid-Based Dermatology Products

  The Brazilian Ministério da Saúde issued regulatory approvals for seven of Sonoma’s non-steroidal and non-antibiotic topical dermatology products.

  October 31, 2017

   · 

  5 min read
• Median Technologies Adds MediScan to Its Product Portfolio

  Median Technologies intends to leverage Mediscan for strengthening the commercial development and market penetration of its application portfolio in Asia and more specifically in China.

  October 31, 2017

   · 

  3 min read
• Drug Development

  Mustang Bio Reports Preclinical Data on Regional Delivery of MB-103 HER2 Chimeric Antigen Receptor Engineered T (CAR T) Cells to Target HER2+ Breast Cancer Metastasis to the Brain

  The data supports clinical development of MB-103 HER2 CAR T cell therapy.

  October 31, 2017

   · 

  4 min read
• Business

  Intellia Therapeutics Announces Third Quarter 2017 Financial Results

  The Company made considerable progress in its Transthyretin Amyloidosis program using its proprietary lipid nanoparticle delivery system.

  October 31, 2017

   · 

  13 min read
• Business

  Protalix BioTherapeutics to Hold Third Quarter 2017 Financial Results and Corporate Update Conference Call on November 8, 2017

  The company will provide a corporate update on Wednesday, November 8, 2017 at 8:30 am ET.

  October 31, 2017

   · 

  2 min read
• Drug Development

  Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes

  Janssen sponsored the application for Fast Track designation utilizing preliminary data from IMerge, the ongoing clinical trial being conducted by Janssen in lower risk MDS.

  October 31, 2017

   · 

  7 min read
• Business

  Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2017 Financial Results

  The company has focused on quality execution of our clinical studies in postpartum depression, which will inform our later stage clinical development plans for this important underserved patient population.

  October 31, 2017

   · 

  9 min read